The Royal Marsden Hospital pilot tamoxifen chemoprevention trial
- 1 January 1994
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 31 (1), 73-82
- https://doi.org/10.1007/bf00689678
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- The case for clinical trials of tamoxifen for prevention of breast cancerThe Lancet, 1992
- Tamoxifen: disease prevention or disease substitution?The Lancet, 1992
- Transvaginal color Doppler in gynecologyUltrasound in Obstetrics & Gynecology, 1991
- Synthetic estrogens and tamoxifen as promoters of hepatocarcinogenesisPreventive Medicine, 1991
- Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programmeEuropean Journal of Cancer and Clinical Oncology, 1990
- Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifenAtherosclerosis, 1984
- Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomataEuropean Journal of Cancer (1965), 1976